Axogen, Inc. — Director's Dealing 2018

Nov 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-11-13

Reporting Person: DeVinney Erick Wayne (VP, Clinical&Translational Sc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-13	Common Stock	M	35000	$2.74	Acquired	40018	Direct
2018-11-13	Common Stock	F	2882	$33.28	Disposed	37136	Direct
2018-11-13	Common Stock	M	274	$0.27	Acquired	37410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-13	Employee Stock Option (right to purchase)	$2.74	M	35000	Disposed	2018-12-16	Common Stock (35000)	Direct
2018-11-13	Employee Stock Option (right to purchase)	$0.27	M	274	Disposed	2018-11-18	Common Stock (274)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 35,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 32,118 shares of common stock.